Olfaction: Minority odors get equal say

  1. Priyanka Gupta
  2. Upinder S Bhalla  Is a corresponding author
  1. National Centre for Biological Sciences, Tata Institute of Fundamental Research, India
  2. Cold Spring Harbor Laboratory, United States

How well could you see a small green leaf if your world was enveloped in a bright purple haze? You would probably struggle to see it at all. But what if instead of detecting colors, you were detecting smells? In this case, you might detect the equivalent of the leaf pretty clearly, but hardly even notice the equivalent of the purple haze. Now, in eLife, Alexander Fleischman and colleagues – including Benjamin Roland, Rebecca Jordan and Dara Sosulski as joint first authors – report on the neural mechanisms that allow information about ‘minority’ odors to be detected through the overwhelming haze of another smell (Roland et al., 2016).

Scents are detected when odor molecules bind to odorant receptors on the surface of olfactory receptor neurons. These neurons then send signals to other neurons in a structure called the olfactory bulb, which processes this information and sends it to other olfactory regions in the brain.

To investigate the neural activity that underlies odor detection, Roland et al. – who are based at a number of institutions in France, Germany, the UK and the US – have revisited the ‘monoclonal nose’ mouse, an intriguing mouse model that was first reported in 2008 (Fleischmann et al., 2008). Mice normally express about 1100 subtypes of odorant receptor and scatter these evenly over several million receptor neurons (with each receptor neuron having one odorant receptor subtype). However, monoclonal nose mice express the same receptor (called M71) in 95% of their receptor neurons (Figure 1).

The olfactory response in M71 transgenic mice. 

M71 transgenic mice are genetically modified to over-express the M71 receptor (shown in purple) in olfactory receptor neurons (top). However, mice can still detect other ‘minority’ odors because the neurons in the olfactory bulb (which receive signals from the olfactory receptor neurons) become less sensitive to signals from the dominant M71 receptors, and more sensitive to signals from other receptors (shown here in yellow, green, black and blue). The heights of the sliders in the ovals represent the level of gain in that circuit: high gain leads to high sensitivity. This ultimately enables each odor to produce an equal-sized output from the olfactory bulb (represented by the width of the arrows at the bottom of the figure).

One of the more unexpected findings of the 2008 study was the apparent inability of these mice to detect acetophenone: this was surprising because acetophenone (which is found in mouse urine) is the primary molecule that activates the M71 receptor. The study involved a behavioral task in which the animals had to discriminate unscented air from air that contained various concentrations of odors. The M71 transgenic mice were capable of quite subtle discriminations for all the tested odors except acetophenone.

Roland et al. now confirm the above behavior but also show that M71 transgenic mice start sniffing when exposed to acetophenone, suggesting that they can in fact detect this odor. If the earlier results were unexpected, the new data are even more intriguing and open up possibilities for teasing apart the mechanisms that underlie these apparently contradictory behaviors.

As a starting point, Roland et al. used a wide range of measures to examine what goes on at the output of the olfactory bulb in the M71 transgenic mice. For example, they used multiphoton imaging to record the activity of populations of neurons called mitral cells that transmit information from the bulb to the other olfactory regions of the brain. They also used whole-cell patch-clamp recordings to acquire detailed readouts from individual mitral cells in both anesthetized and awake mice. These measurements showed that the responses of the mitral cells in M71 transgenic mice are very similar to those of normal mice. The fraction of cells that respond to odors, including acetophenone, was indistinguishable from that seen in normal mice. The same was true for the time courses of the responses, and also for the dependence of odor-driven mitral cell activity on the mouse’s breathing patterns. The only apparent difference was that the output responses were more variable in the transgenic mice, and were slightly weaker to non-acetophenone odors.

This is rather impressive from a computational perspective. Not only does the olfactory system amplify responses to weak odorant inputs (that is, odors other than acetophenone) in the M71 transgenic mice, it also suppresses the massive sensory input (from acetophenone) that drives 95% of the sensory neurons (Figure 1). This normalization preserves much of the information about the detected odors despite the sensory input being hugely distorted.

How does the olfactory bulb accomplish this feat? Roland et al. trace the mechanism to a change in the balance of the inhibitory inputs to the mitral cells. These inputs increase in response to acetophenone, while there is less inhibition of other ‘minority’ odors than there is in normal mice. Based on the results of optical imaging, Roland et al. ascribe this change in the pattern of inhibition to cells called periglomerular cells that are found in the input layer of the olfactory bulb, but other explanations are also possible (Mori et al., 1999; Boyd et al., 2012; Kato et al., 2013; Miyamichi et al., 2013; Banerjee et al., 2015). Future work can build on the results of Roland et al. and isolate the contributions of the various olfactory circuit elements using modern genetic approaches and the large battery of tools that neuroscientists can use to manipulate neuronal activity.

One peculiarity that remains to be resolved is the discrepancy between the neuronal and behavioral responses of M71 transgenic mice to acetophenone. However, the study by Roland et al. sets up a powerful system for understanding the computations that occur in the first stages of the olfactory system to allow different smells to be detected.

In the language of electronic circuit theory, the olfactory bulb employs a “gain-control” layer early in processing to suppress large swings in the size of the input signals it receives. The outcome of such filtering (as seen in M71 transgenic mice) is exactly what one sees in an electronic circuit forced to find a small signal on a huge background. The circuit and bulb both become a little less sensitive and a little noisier. However, a typical electronic circuit has to do this for just one signal. The remarkable accomplishment of the olfactory bulb, as highlighted by Roland, Jordan, Sosulski, Fleischman and colleagues, is to do this for a variety of different signals.

References

Article and author information

Author details

  1. Priyanka Gupta

    1. National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India
    2. Cold Spring Harbor Laboratory, Cold Spring Harbor, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Upinder S Bhalla, eLife Reviewing Editor

    National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India
    For correspondence
    bhalla@ncbs.res.in
    Competing interests
    The authors declare that no competing interests exist.

Publication history

  1. Version of Record published: June 23, 2016 (version 1)

Copyright

© 2016, Gupta et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,049
    Page views
  • 132
    Downloads
  • 0
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Priyanka Gupta
  2. Upinder S Bhalla
(2016)
Olfaction: Minority odors get equal say
eLife 5:e18037.
https://doi.org/10.7554/eLife.18037
  1. Further reading

Further reading

    1. Neuroscience
    Daichi Sasaki, Ken Imai ... Ko Matsui
    Research Article

    The presence of global synchronization of vasomotion induced by oscillating visual stimuli was identified in the mouse brain. Endogenous autofluorescence was used and the vessel ‘shadow’ was quantified to evaluate the magnitude of the frequency-locked vasomotion. This method allows vasomotion to be easily quantified in non-transgenic wild-type mice using either the wide-field macro-zoom microscopy or the deep-brain fiber photometry methods. Vertical stripes horizontally oscillating at a low temporal frequency (0.25 Hz) were presented to the awake mouse, and oscillatory vasomotion locked to the temporal frequency of the visual stimulation was induced not only in the primary visual cortex but across a wide surface area of the cortex and the cerebellum. The visually induced vasomotion adapted to a wide range of stimulation parameters. Repeated trials of the visual stimulus presentations resulted in the plastic entrainment of vasomotion. Horizontally oscillating visual stimulus is known to induce horizontal optokinetic response (HOKR). The amplitude of the eye movement is known to increase with repeated training sessions, and the flocculus region of the cerebellum is known to be essential for this learning to occur. Here, we show a strong correlation between the average HOKR performance gain and the vasomotion entrainment magnitude in the cerebellar flocculus. Therefore, the plasticity of vasomotion and neuronal circuits appeared to occur in parallel. Efficient energy delivery by the entrained vasomotion may contribute to meeting the energy demand for increased coordinated neuronal activity and the subsequent neuronal circuit reorganization.

    1. Medicine
    2. Neuroscience
    Flora Moujaes, Jie Lisa Ji ... Alan Anticevic
    Research Article

    Background:

    Ketamine has emerged as one of the most promising therapies for treatment-resistant depression. However, inter-individual variability in response to ketamine is still not well understood and it is unclear how ketamine’s molecular mechanisms connect to its neural and behavioral effects.

    Methods:

    We conducted a single-blind placebo-controlled study, with participants blinded to their treatment condition. 40 healthy participants received acute ketamine (initial bolus 0.23 mg/kg, continuous infusion 0.58 mg/kg/hr). We quantified resting-state functional connectivity via data-driven global brain connectivity and related it to individual ketamine-induced symptom variation and cortical gene expression targets.

    Results:

    We found that: (i) both the neural and behavioral effects of acute ketamine are multi-dimensional, reflecting robust inter-individual variability; (ii) ketamine’s data-driven principal neural gradient effect matched somatostatin (SST) and parvalbumin (PVALB) cortical gene expression patterns in humans, while the mean effect did not; and (iii) behavioral data-driven individual symptom variation mapped onto distinct neural gradients of ketamine, which were resolvable at the single-subject level.

    Conclusions:

    These results highlight the importance of considering individual behavioral and neural variation in response to ketamine. They also have implications for the development of individually precise pharmacological biomarkers for treatment selection in psychiatry.

    Funding:

    This study was supported by NIH grants DP5OD012109-01 (A.A.), 1U01MH121766 (A.A.), R01MH112746 (J.D.M.), 5R01MH112189 (A.A.), 5R01MH108590 (A.A.), NIAAA grant 2P50AA012870-11 (A.A.); NSF NeuroNex grant 2015276 (J.D.M.); Brain and Behavior Research Foundation Young Investigator Award (A.A.); SFARI Pilot Award (J.D.M., A.A.); Heffter Research Institute (Grant No. 1–190420) (FXV, KHP); Swiss Neuromatrix Foundation (Grant No. 2016–0111) (FXV, KHP); Swiss National Science Foundation under the framework of Neuron Cofund (Grant No. 01EW1908) (KHP); Usona Institute (2015 – 2056) (FXV).

    Clinical trial number:

    NCT03842800